These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12991150)

  • 21. ANTIHYALURONIDASE STUDIES OF SERA FROM PATIENTS WITH RHEUMATIC FEVER, STREPTOCOCCAL INFECTIONS, AND MISCELLANEOUS NON-STREPTOCOCCAL DISEASES.
    Quinn RW
    J Clin Invest; 1948 Jul; 27(4):471-5. PubMed ID: 16695567
    [No Abstract]   [Full Text] [Related]  

  • 22. Antihyaluronidase content of serum in children suffering from hemolytic streptococcal infections, rheumatic fever and other diseases.
    STOPPELMAN MR
    Acta Paediatr (Stockh); 1950; 39(6):510-23. PubMed ID: 14846612
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunologic and biochemical studies in infants and children with special reference to rheumatic fever; inhibition of hyaluronidase by sera.
    EPSTEIN N; LUBSCHEZ RL
    Pediatrics; 1949 Nov; 4(5):569-78. PubMed ID: 15391040
    [No Abstract]   [Full Text] [Related]  

  • 24. Response of the serum hyaluronidase inhibitor and mucoproteins to adrenocorticotropic hormone in rheumatic states. Mucolytic enzyme systems XV.
    ADAMS FH; KELLEY VC; DWAN PF; GLICK D
    Pediatrics; 1951 Apr; 7(4):472-82. PubMed ID: 14827651
    [No Abstract]   [Full Text] [Related]  

  • 25. Relations of hyaluronidase to salicylates and rheumatic fever.
    JAWORSKI AA; FARLEY JE; BARRET J; JAWORSKI RA
    J Pediatr; 1950 Nov; 37(5):697-708. PubMed ID: 14784922
    [No Abstract]   [Full Text] [Related]  

  • 26. [Investigations on the hyaluronidase content of healthy individuals & rheumatic patients and on the inhibition of the activity of hyaluronidase].
    HARTMANN F; MATIJEVIC G
    Z Rheumaforsch; 1952 Feb; 11(1-2):23-31. PubMed ID: 14943193
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyaluronidase inhibition in human pregnancy and menstruation; a study of the nonspecific serum inhibitor.
    PLOMAN L
    Acta Endocrinol Suppl (Copenh); 1953; 12(14):27-40. PubMed ID: 13057526
    [No Abstract]   [Full Text] [Related]  

  • 28. Antihyaluronidase studies in rheumatic fever and other diseases.
    QUINN RW
    Ann Rheum Dis; 1948 Dec; 7(4):260. PubMed ID: 18225108
    [No Abstract]   [Full Text] [Related]  

  • 29. [A method for determination of antistreptococcal hyaluronidase; levels in normal subjects and in rheumatic fever; preliminary report].
    FABER V; SCHMITH K
    Ugeskr Laeger; 1953 Jan; 115(2):37-43. PubMed ID: 13049660
    [No Abstract]   [Full Text] [Related]  

  • 30. The antihyaluronidase content of blood serum; a study of sera from patients with rheumatic fever, streptococcal infection, miscellaneous non-streptococcal diseases, and from normal individuals of different ages.
    QUINN RW
    Ann N Y Acad Sci; 1950 May; 52(7):1118-24. PubMed ID: 15426135
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyaluronidase inhibition by sodium salicylate in rheumatic fever.
    GUERRA F
    Science; 1946 Jun; 103(2684):686. PubMed ID: 20984259
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship of the liver to the serum nonspecific hyaluronidase inhibitor.
    COLE JW; CEBUL FA; HOLDEN WD
    Surgery; 1952 Nov; 32(5):828-34. PubMed ID: 13005308
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dynamics of nonspecific antihyaluronidase of the blood in children with active rheumatism].
    IGNATOVA MS
    Pediatriia; 1958 Mar; 41(3):66-73. PubMed ID: 13553697
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyaluronidase spread and the effect of salicylates in rheumatic fever.
    ATLAS DH; GABERMAN P; EISENBERG H
    Ann Rheum Dis; 1951 Dec; 10(4):418-26. PubMed ID: 14895084
    [No Abstract]   [Full Text] [Related]  

  • 35. Absence of a relationship between ceruloplasmin and nonspecific hyaluronidase inhibitor.
    RANTZ LA; RANDALL E
    AMA Arch Intern Med; 1958 Feb; 101(2):252-3. PubMed ID: 13497322
    [No Abstract]   [Full Text] [Related]  

  • 36. Properdin system and nonspecific inhibitor of hyaluronidase.
    HADIDIAN Z; MAHLER IR; MURPHY MM
    Proc Soc Exp Biol Med; 1957 Jun; 95(2):202-3. PubMed ID: 13441684
    [No Abstract]   [Full Text] [Related]  

  • 37. [Data on the serological nature of rheumatism in children. I. On serum antihyaluronidase in children with rheumatism].
    FEL' VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():132-6. PubMed ID: 13698671
    [No Abstract]   [Full Text] [Related]  

  • 38. [EVALUATION OF THE ANTISTREPTOLYSIN-O AND ANTISTREPTOHYALURONIDASE IN THE SEROLOGY OF RHEUMATIC FEVER].
    ZAVAZAL V
    Plzen Lek Sb; 1964; 23():19-29. PubMed ID: 14320064
    [No Abstract]   [Full Text] [Related]  

  • 39. Mucolytic enzyme systems. XVII. Purification of the nonspecific hyaluronidase inhibitor in human blood.
    WATTENBERG LW; GLICK D
    Arch Biochem Biophys; 1952 Feb; 35(2):290-304. PubMed ID: 14924650
    [No Abstract]   [Full Text] [Related]  

  • 40. [THE SIGNIFICANCE OF SEROLOGICAL METHODS FOR THE DETERMINATION OF IMMUNOLOGIC REACTIVITY AND FOR THE EVALUATION OF THE CLINICAL STATE IN PATIENTS WITH RHEUMATIC FEVER].
    ZAVAZAL V; DORT V
    Z Rheumaforsch; 1963 Dec; 22():468-72. PubMed ID: 14113721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.